Harmony Biosciences Holdings, Inc. (HRMY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 50M 100M 150M Q2 '20: 55.4M Q3 '20: 55.1M Q4 '20: 55.8M Q1 '21: 58.1M Q2 '21: 62.7M Q3 '21: 66.5M Q4 '21: 68.1M Q1 '22: 70.2M Q2 '22: 73.3M Q3 '22: 77.3M Q4 '22: 79.3M Q1 '23: 84.3M Q2 '23: 88.6M Q3 '23: 91.6M Q4 '23: 97.4M Q1 '24: 102.1M Q2 '24: 106M Q3 '24: 110.2M Q4 '24: 110.9M Q1 '25: 114.4M Q2 '25: 116M Q3 '25: 117.9M Q4 '25: 119.5M Q1 '26: 120.5M Q2 '26: 124.5M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Gross Profit TTM

0 250M 500M 750M Q4 '20: 132M Q1 '21: 164.9M Q2 '21: 194.5M Q3 '21: 222.9M Q4 '21: 249.9M Q1 '22: 271.3M Q2 '22: 298.2M Q3 '22: 326.3M Q4 '22: 354.4M Q1 '23: 382.1M Q2 '23: 403.2M Q3 '23: 436.9M Q4 '23: 460.8M Q1 '24: 489.6M Q2 '24: 521M Q3 '24: 536.3M Q4 '24: 557.9M Q1 '25: 583.5M Q2 '25: 605.2M Q3 '25: 641.7M Q4 '25: 670.1M Q1 '26: 688.2M Q2 '26: 724M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-80M 0 80M 160M 240M Q2 '20: -65.8M Q3 '20: -25.6M Q4 '20: 15.8M Q1 '21: 40M Q2 '21: 56M Q3 '21: 66.7M Q4 '21: 87.5M Q1 '22: 100.6M Q2 '22: 110.4M Q3 '22: 101.2M Q4 '22: 120.2M Q1 '23: 133.1M Q2 '23: 146.8M Q3 '23: 199.4M Q4 '23: 192M Q1 '24: 203.6M Q2 '24: 178.1M Q3 '24: 175.3M Q4 '24: 190.8M Q1 '25: 195M Q2 '25: 221.9M Q3 '25: 225.6M Q4 '25: 208.5M Q1 '26: 189.5M Q2 '26: 230.7M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Net Income TTM

-140M -70M 0 70M 140M 210M Q2 '20: -107M Q3 '20: -73.2M Q4 '20: -36.9M Q1 '21: 9.1M Q2 '21: 23.2M Q3 '21: 11.7M Q4 '21: 34.6M Q1 '22: 48.7M Q2 '22: 58.1M Q3 '22: 155.7M Q4 '22: 181.5M Q1 '23: 189.5M Q2 '23: 200.2M Q3 '23: 150.8M Q4 '23: 128.9M Q1 '24: 137.7M Q2 '24: 115M Q3 '24: 122.6M Q4 '24: 145.5M Q1 '25: 152.7M Q2 '25: 180.9M Q3 '25: 185.7M Q4 '25: 158.7M Q1 '26: 145.6M Q2 '26: 181.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Cost of Revenue TTM

0 90M 180M 270M Q4 '20: 27.7M Q1 '21: 34.7M Q2 '21: 40.9M Q3 '21: 47.6M Q4 '21: 55.5M Q1 '22: 59.8M Q2 '22: 66.1M Q3 '22: 74.4M Q4 '22: 83.5M Q1 '23: 89.5M Q2 '23: 95.6M Q3 '23: 105M Q4 '23: 121.2M Q1 '24: 127.9M Q2 '24: 135.1M Q3 '24: 145.6M Q4 '24: 156.8M Q1 '25: 161.3M Q2 '25: 167.3M Q3 '25: 184.2M Q4 '25: 198.3M Q1 '26: 210.9M Q2 '26: 235.9M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-150M 0 150M 300M 450M Q3 '20: -37M Q4 '20: -3M Q1 '21: 36.2M Q2 '21: 49.5M Q3 '21: 71.1M Q4 '21: 98.6M Q1 '22: 114.9M Q2 '22: 130.5M Q3 '22: 155.3M Q4 '22: 144.5M Q1 '23: 158.2M Q2 '23: 161.5M Q3 '23: 169.4M Q4 '23: 219.4M Q1 '24: 208M Q2 '24: 213.5M Q3 '24: 220.9M Q4 '24: 219.8M Q1 '25: 222.7M Q2 '25: 259.4M Q3 '25: 297.6M Q4 '25: 348.2M Q1 '26: 342M Q2 '26: 355.1M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 150M 300M 450M Q2 '21: 49.3M Q3 '21: 70.8M Q4 '21: 98.3M Q1 '22: 114.5M Q2 '22: 130.4M Q3 '22: 155.1M Q4 '22: 144.3M Q2 '24: 212.8M Q3 '24: 220.2M Q4 '24: 218.7M Q1 '25: 221.4M Q2 '25: 258.7M Q3 '25: 296.9M Q4 '25: 347.9M Q3 '21 Q1 '22 Q3 '22 Q2 '24 Q4 '24 Q2 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q3 '19: 7.8M Q1 '20: 7.8M Q2 '20: 7.8M Q3 '20: 30.2M Q1 '21: 58.8M Q2 '21: 58.6M Q3 '21: 57.7M Q1 '22: 60.6M Q2 '22: 60.9M Q3 '22: 61.2M Q1 '23: 61.2M Q2 '23: 60.7M Q3 '23: 60.7M Q1 '24: 57.6M Q2 '24: 57.5M Q3 '24: 58.1M Q1 '25: 58.5M Q2 '25: 58.4M Q3 '25: 58.7M Q1 '26: 58.8M Q2 '26: 58.8M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.00 4.00 6.00 Q2 '21: 5.53 Q3 '21: 5.50 Q4 '21: 0.58 Q1 '22: 0.80 Q2 '22: 0.95 Q3 '22: 2.56 Q4 '22: 2.97 Q1 '23: 3.10 Q2 '23: 3.27 Q3 '23: 2.46 Q4 '23: 2.12 Q1 '24: 2.31 Q2 '24: 1.95 Q3 '24: 2.11 Q4 '24: 2.51 Q1 '25: 2.62 Q2 '25: 3.10 Q3 '25: 3.18 Q4 '25: 2.72 Q1 '26: 2.49 Q2 '26: 3.09 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.